Hubei Dinglong CO.,Ltd.

XSEC:300054 Stock Report

Market Cap: CN¥25.2b

Hubei DinglongLtd Valuation

Is 300054 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300054 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300054 (CN¥26.9) is trading above our estimate of fair value (CN¥24)

Significantly Below Fair Value: 300054 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300054?

Other financial metrics that can be useful for relative valuation.

300054 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue8x
Enterprise Value/EBITDA35.7x
PEG Ratio1.9x

Price to Earnings Ratio vs Peers

How does 300054's PE Ratio compare to its peers?

The above table shows the PE ratio for 300054 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average41.9x
600873 MeiHua Holdings GroupLtd
9.2x8.4%CN¥27.7b
300285 Shandong Sinocera Functional Material
30.3x26.5%CN¥18.5b
688065 Cathay Biotech
69.5xn/aCN¥27.7b
300395 Hubei Feilihua Quartz Glass
58.6x38.7%CN¥21.2b
300054 Hubei DinglongLtd
59.8x32.1%CN¥25.2b

Price-To-Earnings vs Peers: 300054 is expensive based on its Price-To-Earnings Ratio (59.8x) compared to the peer average (42.7x).


Price to Earnings Ratio vs Industry

How does 300054's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a38.3%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a38.3%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 300054 is expensive based on its Price-To-Earnings Ratio (59.8x) compared to the CN Chemicals industry average (33.5x).


Price to Earnings Ratio vs Fair Ratio

What is 300054's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300054 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio59.8x
Fair PE Ratio28.8x

Price-To-Earnings vs Fair Ratio: 300054 is expensive based on its Price-To-Earnings Ratio (59.8x) compared to the estimated Fair Price-To-Earnings Ratio (28.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 300054 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥26.90
CN¥33.00
+22.7%
4.3%CN¥35.00CN¥32.00n/a3
Oct ’25CN¥23.85
CN¥25.00
+4.8%
5.7%CN¥27.00CN¥24.00n/a3
Sep ’25CN¥19.60
CN¥25.00
+27.6%
5.7%CN¥27.00CN¥24.00n/a3
Aug ’25CN¥21.76
CN¥25.67
+18.0%
4.9%CN¥27.00CN¥24.00n/a3
Jul ’25CN¥22.91
CN¥25.00
+9.1%
5.7%CN¥27.00CN¥24.00n/a3
Jun ’25CN¥22.49
CN¥25.00
+11.2%
5.7%CN¥27.00CN¥24.00n/a3
May ’25CN¥23.69
CN¥25.00
+5.5%
5.7%CN¥27.00CN¥24.00n/a3
Apr ’25CN¥21.83
CN¥22.75
+4.2%
3.3%CN¥23.50CN¥22.00n/a2
Mar ’25CN¥20.99
CN¥22.75
+8.4%
3.3%CN¥23.50CN¥22.00n/a2
Feb ’25CN¥17.39
CN¥22.75
+30.8%
3.3%CN¥23.50CN¥22.00n/a2
Jan ’25CN¥24.20
CN¥25.50
+5.4%
2.0%CN¥26.00CN¥25.00n/a2
Dec ’24CN¥24.70
CN¥26.67
+8.0%
6.4%CN¥29.00CN¥25.00n/a3
Nov ’24CN¥23.90
CN¥27.50
+15.1%
7.5%CN¥30.00CN¥25.00CN¥26.024
Oct ’24CN¥20.96
CN¥27.50
+31.2%
7.5%CN¥30.00CN¥25.00CN¥23.854
Sep ’24CN¥20.95
CN¥27.50
+31.3%
7.5%CN¥30.00CN¥25.00CN¥19.604
Aug ’24CN¥23.03
CN¥30.00
+30.3%
2.4%CN¥31.00CN¥29.00CN¥21.764
Jul ’24CN¥24.73
CN¥30.00
+21.3%
2.4%CN¥31.00CN¥29.00CN¥22.914
Jun ’24CN¥26.20
CN¥30.00
+14.5%
2.4%CN¥31.00CN¥29.00CN¥22.494
May ’24CN¥26.52
CN¥30.00
+13.1%
2.4%CN¥31.00CN¥29.00CN¥23.694
Apr ’24CN¥24.50
CN¥28.17
+15.0%
2.2%CN¥29.00CN¥27.50CN¥21.833
Mar ’24CN¥22.32
CN¥28.17
+26.2%
2.2%CN¥29.00CN¥27.50CN¥20.993
Feb ’24CN¥23.10
CN¥28.17
+21.9%
2.2%CN¥29.00CN¥27.50CN¥17.393
Jan ’24CN¥21.29
CN¥27.45
+28.9%
1.7%CN¥28.00CN¥26.84CN¥24.203
Dec ’23CN¥22.67
CN¥27.17
+19.9%
1.2%CN¥27.50CN¥26.84CN¥24.702
Nov ’23CN¥20.71
CN¥27.17
+31.2%
1.2%CN¥27.50CN¥26.84CN¥23.902

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies